Stock NAMS FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
19.1 EUR -2.45% Intraday chart for Frazier Lifesciences Acquisition Corporation -1.95% +70.99%
May. 16 Transcript : NewAmsterdam Pharma Company N.V. - Special Call
May. 15 TD Cowen Starts NewAmsterdam Pharma With Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
FRAZIER LIFESCIENCES ACQUISITION CORPORATION Stock Frazier Lifesciences Acquisition Corporation
 1.69B - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 22.1B -
GENMAB A/S Stock Genmab A/S
 18.34B
  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. Charts Frazier Lifesciences Acquisition Corporation
  5. Sector Chart